KKR SAYS IT WILL BUY PHARMERICA FOR $909M

PharMerica, a hospital pharmacy manager, agreed Wednesday to be acquired by private equity firm KKR for $909.4 million in cash. The deal, in which Walgreens Boots Alliance is a minority investor, also includes KKR assuming about $490 million of PharMerica’s debt.